Restoring force development by titin/connectin and assessment of Ig domain unfolding.
Titin/connectin is the main determinant of physiological levels of passive muscle force. This force is generated by the extensible I-band region of the molecule, which is composed of serially-linked immunoglobulin (Ig)-like domains and several unique sequence elements. Here we address the role of titin/connectin in sarcomeres shortened to below the slack length (length attained by an un-activated cell in absence of external forces). Such shortened cells develop so-called restoring forces that re-extend the cells upon relaxation. The experiments that we present are based on a high throughput method with a rapid solution switching system which allows unattached single cardiac myocytes to be activated (resulting in shortening below the slack length) and then to be rapidly relaxed while their maximal re-lengthening velocity is measured at the sarcomere level (dSL/dtmax), with high-resolution imaging techniques. Experiments were carried out on myocytes that express different isoforms of titin/connectin. We measured the relation between dSL/dtmax and the minimal SL during contraction (SLmin) and determined the slope of this relation as a measure of 'restoring stiffness.' We found that the restoring stiffness correlates with the isoform expression profile with myocytes that express high levels of the stiff isoform (N2B) having the highest restoring stiffness. These results support the notion that titin/connectin is a bi-directional spring that develops passive force when stretched above the slack length and restoring force when shortened to below this length. We also discuss in detail the mechanisms that underlie titin/connectin's restoring force development and focus on whether or not unfolding of Ig domains plays a role.
Preetha
Nair
N
Department VCAPP, Washington State University, Pullman, WA 99164-6520, USA.
Yiming
Wu
W
Helmes
Michiel
M
Norio
Fukuda
F
Siegfried
Labeit
L
Granzier
Henk
H
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001696:Biomechanical Phenomena; D002417:Cattle; D002469:Cell Separation / Q000379:methods; D064211:Connectin; D006352:Heart Ventricles / Q000187:drug effects; D066298:In Vitro Techniques; D008954:Models, Biological; D009124:Muscle Proteins / Q000737:chemistry / Q000502:physiology*; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D017510:Protein Folding; D020033:Protein Isoforms / Q000502:physiology; D011494:Protein Kinases / Q000737:chemistry / Q000502:physiology*; D017434:Protein Structure, Tertiary; D051381:Rats; D012518:Sarcomeres / Q000502:physiology; D013696:Temperature; D016276:Ventricular Function
D064211:Connectin; D009124:Muscle Proteins; D020033:Protein Isoforms; D000255:Adenosine Triphosphate; D011494:Protein Kinases